$GIFT
GIFTIFY, INC.

2024 Q3 Form 10-Q Financial Statement

#000149315224032141 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2
Revenue $23.21M $20.02M $721.5K
YoY Change 3951.35% 2674.89% -60.16%
Cost Of Revenue $20.22M $16.76M $18.47M
YoY Change 14.69% -9.28%
Gross Profit $2.991M $3.260M $2.618M
YoY Change 16.03% 24.56%
Gross Profit Margin 12.88% 16.29% 362.8%
Selling, General & Admin $5.909M $9.832M $2.454M
YoY Change 739.82% 300.73% 66.3%
% of Gross Profit 197.57% 301.56% 93.74%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $6.771M $10.74M $2.555M
YoY Change 787.43% 320.47% 27.48%
Operating Profit -$3.780M -$7.482M -$1.834M
YoY Change 1889.01% 308.09% 849.62%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$281.0K -$262.2K -$7.170K
YoY Change 14563.52% 3557.14% 1300.39%
Pretax Income -$4.061M -$7.745M -$686.7K
YoY Change 629.2% 1027.88%
Income Tax
% Of Pretax Income
Net Earnings -$4.061M -$7.745M -$1.841M
YoY Change 2015.51% 320.75% 850.82%
Net Earnings / Revenue -17.5% -38.68% -255.12%
Basic Earnings Per Share -$0.16 -$0.30 -$0.12
Diluted Earnings Per Share -$0.16 -$0.30 -$0.12
COMMON SHARES
Basic Shares Outstanding 25.91M shares 25.59M shares 15.62M shares
Diluted Shares Outstanding 25.96M shares 25.75M shares 15.98M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $3.091M $4.664M $2.134M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $4.396M $5.240M
Prepaid Expenses
Receivables $1.203M $901.8K $138.5K
Other Receivables
Total Short-Term Assets $8.804M $11.01M $2.525M
YoY Change 203.37% 336.01% 1.71%
LONG-TERM ASSETS
Property, Plant & Equipment $2.302M $2.331M
YoY Change
Goodwill $20.01M $20.01M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $28.73M $29.44M $293.9K
YoY Change 10489.02% 9917.96% -47.11%
TOTAL ASSETS
Total Short-Term Assets $8.804M $11.01M $2.525M
Total Long-Term Assets $28.73M $29.44M $293.9K
Total Assets $37.54M $40.46M $2.819M
YoY Change 1082.91% 1334.92% -7.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.995M $1.708M $1.315M
YoY Change 71.22% 29.88% 10.85%
Accrued Expenses $1.396M $1.381M $470.7K
YoY Change 150.98% 193.41% -35.02%
Deferred Revenue $78.40K $114.0K $139.8K
YoY Change -33.94% -18.43% -29.57%
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.99M $12.15M $2.114M
YoY Change 444.22% 474.53% -47.88%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $10.99M $12.15M $2.114M
Total Long-Term Liabilities
Total Liabilities $15.40M $16.64M $3.093M
YoY Change 417.17% 437.78% -36.3%
SHAREHOLDERS EQUITY
Retained Earnings -$84.46M -$80.40M -$63.84M
YoY Change 31.91% 25.95% 6.02%
Common Stock $26.13K $25.91K $16.51K
YoY Change 55.94% 56.95% 16.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $22.14M $23.82M -$273.9K
YoY Change
Total Liabilities & Shareholders Equity $37.54M $40.46M $2.819M
YoY Change 1082.91% 1334.92% -7.22%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income -$4.061M -$7.745M -$1.841M
YoY Change 2015.51% 320.75% 850.82%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Trading Symbol
TradingSymbol
RSTN
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2835513 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15046311 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5638341 usd
CY2023Q2 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
223268 usd
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
681474 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
607917 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
75000 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
352308 usd
us-gaap Net Income Loss
NetIncomeLoss
-10935366 usd
us-gaap Net Income Loss
NetIncomeLoss
-1117035 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.43
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.43
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13774292 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25751441 shares
dei Entity Central Index Key
EntityCentralIndexKey
0001760233
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-553640 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
205235 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-242807 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-222972 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-208864 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-138327 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-94481 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2341031 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-437725 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
449646 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
450000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-449646 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-450000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
53772243 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
51316611 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
52839180 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
50972869 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
500000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2921500 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3354563 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
343742 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
563886 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-543983 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4099737 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2040680 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4663623 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1496697 usd
us-gaap Interest Paid Net
InterestPaidNet
510417 usd
us-gaap Interest Paid Net
InterestPaidNet
352308 usd
RSTN Operating Lease Rightofuse Assets Obtained In Exchange For New Operating Lease Liabilities
OperatingLeaseRightofuseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities
1395541 usd
CY2024Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
usd
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
RSTN Fair Value Of Vested Stock Options
FairValueOfVestedStockOptions
usd
RSTN Fair Value Of Vested Restricted Common Stock
FairValueOfVestedRestrictedCommonStock
usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
RSTN Operating Lease Rightofuse Assets Obtained In Exchange For New Operating Lease Liabilities
OperatingLeaseRightofuseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities
usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
usd
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.001
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25912263 shares
CY2024Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
1258826 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1258826 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4099737 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1681165 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
4152273 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
177119 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
10110294 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2563312 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
315183 usd
CY2023Q4 us-gaap Deposit Assets
DepositAssets
65556 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6700000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
20007669 usd
CY2023Q4 us-gaap Assets
Assets
39762014 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2218285 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1175934 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
336996 usd
CY2023Q4 us-gaap Line Of Credit
LineOfCredit
6737385 usd
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
40137 usd
CY2024Q2 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
932792 usd
CY2023Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
836509 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
500000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
296937 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
134475 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
12145128 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11979721 usd
CY2024Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
1392355 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1458270 usd
CY2024Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1800000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1800000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1297581 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
202829 usd
CY2024Q2 us-gaap Liabilities
Liabilities
16635064 usd
CY2023Q4 us-gaap Liabilities
Liabilities
15440820 usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25912263 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25912263 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24119967 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24119967 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
25906 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
24114 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
103841872 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
93376244 usd
CY2024Q2 RSTN Common Stock Issuable Shares
CommonStockIssuableShares
350843 shares
CY2023Q4 RSTN Common Stock Issuable Shares
CommonStockIssuableShares
383343 shares
CY2024Q2 RSTN Common Stock Issuable
CommonStockIssuable
350843 usd
CY2023Q4 RSTN Common Stock Issuable
CommonStockIssuable
383343 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-80397873 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-69462507 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
23820748 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
24321194 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
40455812 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
39762014 usd
CY2024Q2 us-gaap Financial Designation Predecessor And Successor Fixed List
FinancialDesignationPredecessorAndSuccessorFixedList
Successor
CY2023Q2 us-gaap Financial Designation Predecessor And Successor Fixed List
FinancialDesignationPredecessorAndSuccessorFixedList
Predecessor
us-gaap Financial Designation Predecessor And Successor Fixed List
FinancialDesignationPredecessorAndSuccessorFixedList
Successor
us-gaap Financial Designation Predecessor And Successor Fixed List
FinancialDesignationPredecessorAndSuccessorFixedList
Predecessor
CY2024Q2 us-gaap Revenues
Revenues
20020502 usd
CY2023Q2 us-gaap Revenues
Revenues
21091657 usd
us-gaap Revenues
Revenues
41542396 usd
us-gaap Revenues
Revenues
45253385 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
16760007 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
18474119 usd
us-gaap Cost Of Revenue
CostOfRevenue
35024625 usd
us-gaap Cost Of Revenue
CostOfRevenue
39722197 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
3260495 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
2617538 usd
us-gaap Gross Profit
GrossProfit
6517771 usd
us-gaap Gross Profit
GrossProfit
5531188 usd
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9832270 usd
CY2024Q2 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
302737 usd
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
535971 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1215834 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
150000 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
10742924 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
3133781 usd
us-gaap Operating Expenses
OperatingExpenses
16943619 usd
us-gaap Operating Expenses
OperatingExpenses
6324312 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7482429 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-516243 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-10425848 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-793124 usd
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
5223 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
5223 usd
CY2024Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
267440 usd
CY2023Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
170414 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
514741 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-262217 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-170414 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-509518 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-352308 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7744646 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-686657 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10935366 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1145432 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-28397 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-7744646 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-686657 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25751441 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13774292 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25377832 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13774292 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25377832 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13774292 shares
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
25138350 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
5669186 usd
CY2024Q2 RSTN Stock Issued During Period Value Fair Value Of Vested Restricted Stock Units
StockIssuedDuringPeriodValueFairValueOfVestedRestrictedStockUnits
232859 usd
CY2024Q2 RSTN Stock Issued During Period Value Issuance Of Common Stock For Employment Agreements
StockIssuedDuringPeriodValueIssuanceOfCommonStockForEmploymentAgreements
312500 usd
CY2024Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
212499 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-7744646 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
23820748 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
24321194 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
5706311 usd
RSTN Stock Issued During Period Value Fair Value Of Vested Restricted Stock Units
StockIssuedDuringPeriodValueFairValueOfVestedRestrictedStockUnits
964609 usd
RSTN Stock Issued During Period Value Issuance Of Common Stock For Employment Agreements
StockIssuedDuringPeriodValueIssuanceOfCommonStockForEmploymentAgreements
625000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
217500 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
2921500 usd
us-gaap Net Income Loss
NetIncomeLoss
-10935366 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
23820748 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-25828565 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-686657 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-26515222 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-25398187 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-25398187 usd
us-gaap Net Income Loss
NetIncomeLoss
-1117035 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-26515222 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-26515222 usd
us-gaap Financial Designation Predecessor And Successor Fixed List
FinancialDesignationPredecessorAndSuccessorFixedList
Predecessor
us-gaap Net Income Loss
NetIncomeLoss
-1117035 usd
RSTN Fair Value Of Vested Stock Options
FairValueOfVestedStockOptions
5706311 usd
RSTN Fair Value Of Vested Restricted Common Stock
FairValueOfVestedRestrictedCommonStock
1589609 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
217500 usd
us-gaap Depreciation
Depreciation
627706 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
150000 usd
RSTN Accrued Interest
AccruedInterest
-31868 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-779380 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-647865 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1087690 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-370265 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
28735 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
111215 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-155011 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-94481 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-510163 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84A_eus-gaap--UseOfEstimates_zBgOWNQp5HY1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zF9mywaDU106">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the Company’s financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make certain estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and the disclosure of contingent assets and liabilities. Actual results could differ from those estimates. On an ongoing basis, management reviews its estimates and if deemed appropriate, those estimates are adjusted. Significant estimates include those related to assumptions used in valuing inventories at net realizable value, assumptions used in valuing assets acquired in business acquisitions, impairment testing of goodwill and other long-term assets, assumptions used in valuing stock-based compensation, the realizability of deferred tax assets and the related valuation allowance, accruals for potential liabilities, and assumptions used in the determination of the Company’s liquidity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20020502 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21091657 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
41542396 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
45253385 usd
CY2024Q2 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P3Y
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
us-gaap Advertising Expense
AdvertisingExpense
431488 usd
us-gaap Advertising Expense
AdvertisingExpense
449754 usd
us-gaap Financial Designation Predecessor And Successor Fixed List
FinancialDesignationPredecessorAndSuccessorFixedList
Successor
us-gaap Financial Designation Predecessor And Successor Fixed List
FinancialDesignationPredecessorAndSuccessorFixedList
Predecessor
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4501883 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1526882 shares
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_z7modwHIg9sb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zxhJw27RkA2e">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of trade accounts receivable and cash. The credit risk exposure surrounding trade accounts receivable is limited as these amounts represent the timing difference between payments being settled by credit card processors and the cash being provided to the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No significant customers comprised more than <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20240101__20240630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zSQFa80gep34" title="Concentration risk, percentage"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zrujaFJ7eSDk" title="Concentration risk, percentage">10</span></span>% of accounts receivable as of June 30, 2024 and December 31, 2023 or revenue as of and for the period ended June 30, 2024 and 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains a cash balance at financial institutions, which at times exceed the federally insured limit. The Company has not experienced nor expects to experience a loss on this account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p>
us-gaap Financial Designation Predecessor And Successor Fixed List
FinancialDesignationPredecessorAndSuccessorFixedList
Successor
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3012957 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2563312 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
681474 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2331483 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2563312 usd
us-gaap Depreciation
Depreciation
681474 usd
us-gaap Depreciation
Depreciation
627706 usd
us-gaap Financial Designation Predecessor And Successor Fixed List
FinancialDesignationPredecessorAndSuccessorFixedList
Successor
CY2024Q2 us-gaap Goodwill
Goodwill
20007669 usd
CY2023Q4 us-gaap Goodwill
Goodwill
20007669 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6700000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6700000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1215834 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5484166 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6700000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1215834 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5484166 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1016166 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2234000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2234000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5484166 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
315183 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
1395541 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-155011 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1555713 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
337304 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
1395541 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-138327 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1594518 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
296937 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1297581 usd
us-gaap Lease Cost
LeaseCost
201839 usd
us-gaap Lease Cost
LeaseCost
115322 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y6M10D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0800 pure
us-gaap Financial Designation Predecessor And Successor Fixed List
FinancialDesignationPredecessorAndSuccessorFixedList
Successor
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
208164 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
424660 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
438374 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
382954 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
359654 usd
CY2024Q2 RSTN Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
105927 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1919733 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
325215 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1594518 usd
us-gaap Financial Designation Predecessor And Successor Fixed List
FinancialDesignationPredecessorAndSuccessorFixedList
Successor
CY2024Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
7670449 usd
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
6737385 usd
CY2020Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
10000000 usd
CY2020Q4 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0300 pure
CY2020Q4 us-gaap Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
0.065 pure
CY2024Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.12 pure
CY2023Q4 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.12 pure
CY2024Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
1258826 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1258826 usd
us-gaap Financial Designation Predecessor And Successor Fixed List
FinancialDesignationPredecessorAndSuccessorFixedList
Successor
us-gaap Financial Designation Predecessor And Successor Fixed List
FinancialDesignationPredecessorAndSuccessorFixedList
Successor
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25912263 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25912263 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24119967 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24119967 shares
CY2023Q4 RSTN Common Stock Issuable Shares
CommonStockIssuableShares
383343 shares
CY2023Q4 RSTN Common Stock Issuable Value
CommonStockIssuableValue
383000 usd
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
32500 shares
CY2024Q2 RSTN Common Stock Issuable Shares
CommonStockIssuableShares
350843 shares
us-gaap Share Based Compensation
ShareBasedCompensation
964609 usd
us-gaap Financial Designation Predecessor And Successor Fixed List
FinancialDesignationPredecessorAndSuccessorFixedList
Successor
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
743116 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.43
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3405500 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.22
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2834 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.35
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
22500 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.05
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4123282 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.28
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2103647 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.34
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5706311 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
7997509 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y3M10D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
4.20
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1588479 usd

Files In Submission

Name View Source Status
0001493152-24-032141-index-headers.html Edgar Link pending
0001493152-24-032141-index.html Edgar Link pending
0001493152-24-032141.txt Edgar Link pending
0001493152-24-032141-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rstn-20240630.xsd Edgar Link pending
Show.js Edgar Link pending
rstn-20240630_def.xml Edgar Link unprocessable
rstn-20240630_lab.xml Edgar Link unprocessable
rstn-20240630_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
rstn-20240630_cal.xml Edgar Link unprocessable